From large networks to small molecules

Current Opinion in Chemical Biology

Volumn 8, Issue 1, 2004, Pages 81-90

  Sharom, Jeffrey R ^a,b   Bellows, David S ^a   Tyers, Mike ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CHEMICAL GENETICS; DNA REPAIR; DRUG TARGETING; GENE DELETION; GENE INTERACTION; GENOME; GROWTH INHIBITION; INTEGRATION; MOLECULE; NONHUMAN; PHENOTYPE; PREDICTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW;

EID: 1042298842     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2003.12.007     Document Type: Review

References (78)

1. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science. 300:2003;445-452.
2. Giaever G., Chu A.M., Ni L., Connelly C., Riles L., Veronneau S., Dow S., Lucau-Danila A., Anderson K., Andre B. et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 418:2002;387-391 Construction and preliminary phenotypic characterization of 5916 individual gene deletion strains in yeast. Significantly, each deletion strain is uniquely 'bar-coded' with two 20-mer oligonucleotides, which allows the relative abundance of all deletion strains to be assessed by microarray methods after competitive growth under any given condition of interest.
3. Hartman J.L., Garvik B., Hartwell L. Principles for the buffering of genetic variation. Science. 291:2001;1001-1004 A lucid treatise on the principles that govern genetic networks.
4. Gu Z., Steinmetz L.M., Gu X., Scharfe C., Davis R.W., Li W.H. Role of duplicate genes in genetic robustness against null mutations. Nature. 421:2003;63-66.
5. Tong A.H., Evangelista M., Parsons A.B., Xu H., Bader G.D., Page N., Robinson M., Raghibizadeh S., Hogue C.W., Bussey H.et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 294:2001;2364-2368 Describes the Synthetic Genetic Array (SGA) method for systematic mapping of genetic interactions in yeast based on roboticized mating of the complete gene deletion set to any query mutation of interest followed by selection of double mutant haploid cells.
6. Ooi S.L., Shoemaker D.D., Boeke J.D. DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat. Genet. 35:2003;277-286 Describes the Synthetic Lethality Analysis by Microarray (SLAM) method, which allows quantitative assessment of genetic interactions by transformation of the complete yeast deletion set with a query mutation of interest, followed by competitive growth and a barcode microarray readout.
7. Neil J.C., Cameron E.R. Retroviral insertion sites and cancer: fountain of all knowledge? Cancer Cell. 2:2002;253-255.
8. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 421:2003;231-237 Genome-wide application of RNAi-mediated inhibition for detection of gene function in the nematode worm. 86% of the 19 427 predicted genes are surveyed, of which mutant phenotypes are found for over 1700.
9. Wu R.Z., Bailey S.N., Sabatini D.M. Cell-biological applications of transfected-cell microarrays. Trends Cell Biol. 12:2002;485-488.
10. Kunath T., Gish G., Lickert H., Jones N., Pawson T., Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21:2003;559-561 Knockdown of gene expression in ES cells and transgenic mice by short hairpin RNA. Gene function in vivo can be evaluated in a matter of weeks by this method, as opposed to a year or more for conventional gene knockout approaches.
11. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA. 98:2001;4569-4574.
12. Uetz P., Giot L., Cagney G., Mansfield T.A., Judson R.S., Knight J.R., Lockshon D., Narayan V., Srinivasan M., Pochart P. et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:2000;623-627.
13. Gavin A.C., Bosche M., Krause R., Grandi P., Marzioch M., Bauer A., Schultz J., Rick J.M., Michon A.M., Cruciat C.M. et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141-147 One of two reports that describes high-throughput mass spectrometric analysis of protein complexes in yeast.
14. •].
15. von Mering C., Krause R., Snel B., Cornell M., Oliver S.G., Fields S., Bork P. Comparative assessment of large-scale data sets of protein-protein interactions. Nature. 417:2002;399-403.
16. Bader G.D., Hogue C.W. Analyzing yeast protein-protein interaction data obtained from different sources. Nat. Biotechnol. 20:2002;991-997.
17. Ghaemmaghami S., Huh W.K., Bower K., Howson R.W., Belle A., Dephoure N., O'Shea E.K., Weissman J.S. Global analysis of protein expression in yeast. Nature. 425:2003;737-741 Quantitative analysis of abundance for all proteins in yeast by use of a tandem affinity purification (TAP) epitope tag.
18. Huh W.K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., Weissman J.S., O'Shea E.K. Global analysis of protein localization in budding yeast. Nature. 425:2003;686-691 Subcellular localization of 75% of all yeast proteins by use of green fluorescent protein fusions.
19. Ficarro S.B., McCleland M.L., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., Hunt D.F., White F.M. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20:2002;301-305 Over 300 sites of phosphorylation are identified in yeast. Analogous approaches in human samples could in principle provide powerful disease markers that reflect intracellular signaling status.
20. Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21:2003;921-926.
21. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA. 100:2003;6940-6945 Isotopically labeled internal standards are used to accurately quantitate proteins and their modifications.
22. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21:2003;315-318 Quantitative analysis of protein abundance in biological samples using Stable Isotopic Labeling with Amino acids in Cell culture (SILAC), in which samples are differentially labeled with amino acids bearing defined mass isotopes. Of wide potential application in deconvolving complex mixtures and discriminating signal from background contamination.
23. Ranish J.A., Yi E.C., Leslie D.M., Purvine S.O., Goodlett D.R., Eng J., Aebersold R. The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 33:2003;349-355 Application of isotope-coded affinity tag (ICAT) technology to discriminate signal from noise in complex, partially purified samples such as crude immunoprecipitations. Also of wide potential application.
24. Zhu H., Snyder M. Protein chip technology. Curr. Opin. Chem. Biol. 7:2003;55-63.
25. Lee T.I., Rinaldi N.J., Robert F., Odom D.T., Bar-Joseph Z., Gerber G.K., Hannett N.M., Harbison C.T., Thompson C.M., Simon I. et al. Transcriptional regulatory networks in Saccharomyces cerevisiae. Science. 298:2002;799-804.
26. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., Hao Y.L., Ooi C.E., Godwin B., Vitols E. et al. A protein interaction map of Drosophila melanogaster. Science. 302:2003;1727-1736 In the first large-scale analysis of a metazoan interactome, this paper reports 20 439 interactions between 7048 proteins. Graph theory is used to assign a set of 4780 high confidence interactions between 4679 proteins. Known and novel pathways are detected, with both short-range and long-range organization.
27. Reboul J., Vaglio P., Rual J.F., Lamesch P., Martinez M., Armstrong C.M., Li S., Jacotot L., Bertin N., Janky R. et al. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat. Genet. 34:2003;35-41 Over 12 000 nematode open reading frames are cloned in recombination-based vectors for expression and interaction analysis.
28. Walhout A.J., Reboul J., Shtanko O., Bertin N., Vaglio P., Ge H., Lee H., Doucette-Stamm L., Gunsalus K.C., Schetter A.J. et al. Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr. Biol. 12:2002;1952-1958 Combined interaction, expression and phenotypic data are used to generate a map of biological interactions for the nematode germline.
29. Jeong H., Mason S.P., Barabasi A.L., Oltvai Z.N. Lethality and centrality in protein networks. Nature. 411:2001;41-42.
30. Luscombe NM, Qian J, Zhang Z, Johnson T, Gerstein M: The dominance of the population by a selected few: power-law behaviour applies to a wide variety of genomic properties. Genome Biol 2002, 3:RESEARCH0040.
31. Fraser H.B., Hirsh A.E., Steinmetz L.M., Scharfe C., Feldman M.W. Evolutionary rate in the protein interaction network. Science. 296:2002;750-752.
32. Hartwell L.H., Hopfield J.J., Leibler S., Murray A.W. From molecular to modular cell biology. Nature. 402:1999;C47-C52.
33. Rives A.W., Galitski T. Modular organization of cellular networks. Proc. Natl. Acad. Sci. USA. 100:2003;1128-1133.
34. Spirin V., Mirny L.A. Protein complexes and functional modules in molecular networks. Proc. Natl. Acad. Sci. USA. 100:2003;12123-12128.
35. Ravasz E., Somera A.L., Mongru D.A., Oltvai Z.N., Barabasi A.L. Hierarchical organization of modularity in metabolic networks. Science. 297:2002;1551-1555.
36. Bar-Joseph Z., Gerber G.K., Lee T.I., Rinaldi N.J., Yoo J.Y., Robert F., Gordon D.B., Fraenkel E., Jaakkola T.S., Young R.A. et al. Computational discovery of gene modules and regulatory networks. Nat. Biotechnol. 21:2003;1337-1342.
37. Ferrell J.E. Jr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell. Biol. 14:2002;140-148.
38. McAdams H.H., Arkin A. Stochastic mechanisms in gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;814-819.
39. Blake W.J., Kaern M., Cantor C.R., Collins J.J. Noise in eukaryotic gene expression. Nature. 422:2003;633-637.
40. Guet C.C., Elowitz M.B., Hsing W., Leibler S. Combinatorial synthesis of genetic networks. Science. 296:2002;1466-1470 Describes the de novo assembly of transcriptional regulatory networks with various properties.
41. Davidson E.H., McClay D.R., Hood L. Regulatory gene networks and the properties of the developmental process. Proc. Natl. Acad. Sci. USA. 100:2003;1475-1480.
42. Selinger D.W., Wright M.A., Church G.M. On the complete determination of biological systems. Trends Biotechnol. 21:2003;251-254.
43. Aitchison J.D., Galitski T. Inventories to insights. J. Cell. Biol. 161:2003;465-469.
44. Ozier O., Amin N., Ideker T. Global architecture of genetic interactions on the protein network. Nat. Biotechnol. 21:2003;490-491.
45. Peri S., Navarro J.D., Amanchy R., Kristiansen T.Z., Jonnalagadda C.K., Surendranath V., Niranjan V., Muthusamy B., Gandhi T.K., Gronborg M. et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 13:2003;2363-2371 An ambitious effort to manually curate over 300 000 published articles for 2750 non-redundant human proteins.
46. Jansen R., Yu H., Greenbaum D., Kluger Y., Krogan N.J., Chung S., Emili A., Snyder M., Greenblatt J.F., Gerstein M. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science. 302:2003;449-453 A predictive approach that combines various data sources is developed and tested.
47. Bader JS, Chaudhuri A, Chant J: Gaining confidence in high-throughput protein interaction networks. Nat Biotechnol 2004, in press.
48. Przulj N, Wigle D, Jurisica I: Functional topology in a network of protein interactions. Bioinformatics 2004, 19 in press.
49. Stuart J.M., Segal E., Koller D., Kim S.K. A gene-coexpression network for global discovery of conserved genetic modules. Science. 302:2003;249-255 A computational method is used to find correlated gene expression patterns in over 3000 microarray experiments from yeast, worms, fruit flies and humans. Orthologs identified by sequence homology are grouped into 'metagenes', subsets of which are found to be associated with certain core biological functions.
50. Kauffman SA: The Origins of Order. New York: Oxford University Press; 1993.
51. Huang S. Rational drug discovery: what can we learn from regulatory networks? Drug Discov. Today. 7:2002;S163-S169.
52. Levsky J.M., Shenoy S.M., Pezo R.C., Singer R.H. Single-cell gene expression profiling. Science. 297:2002;836-840 Parallel analysis of 11 genes in single tissue culture cells reveals unexpected heterogeneity in the transcriptional response to serum stimulation.
53. Elowitz M.B., Levine A.J., Siggia E.D., Swain P.S. Stochastic gene expression in a single cell. Science. 297:2002;1183-1186 Delineates sources of noise in biological systems, in particular how stochastic effects arise from low-abundance regulators.
54. Chung C.H., Bernard P.S., Perou C.M. Molecular portraits and the family tree of cancer. Nat Genet. 32(Suppl):2002;533-540.
55. Breitkreutz A, Boucher L, Breitkreutz B-J, Sultan M, Jurisica I, Tyers M: Phenotypic and transcriptional plasticity directed by a yeast MAPK network. Genetics 2003, in press.
56. Ideker T., Ozier O., Schwikowski B., Siegel A.F. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics. 18(Suppl 1):2002;S233-S240.
57. Bader G.D., Betel D., Hogue C.W. BIND: the biomolecular interaction network database. Nucleic Acids Res. 31:2003;248-250.
58. Breitkreutz B.J., Stark C., Tyers M. Osprey: a network visualization system. Genome Biol. 4:2003;R22.
59. Hucka M., Finney A., Sauro H.M., Bolouri H., Doyle J.C., Kitano H., Arkin A.P., Bornstein B.J., Bray D., Cornish-Bowden A. et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics. 19:2003;524-531 Describes a new information standard for representation of biological networks.
60. Mitchison T.J. Towards a pharmacological genetics. Chem. Biol. 1:1994;3-6.
61. Hartwell L.H., Szankasi P., Roberts C.J., Murray A.W., Friend S.H. Integrating genetic approaches into the discovery of anticancer drugs. Science. 278:1997;1064-1068.
62. Mayer T.U. Chemical genetics: tailoring tools for cell biology. Trends Cell. Biol. 13:2003;270-277.
63. Kuruvilla F.G., Shamji A.F., Sternson S.M., Hergenrother P.J., Schreiber S.L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature. 416:2002;653-657 A high-density microarray of small molecules is used to identify a compound, uretupamine, that modulates a subset of the functions of the budding yeast signaling protein Ure2.
64. Neckers L. Development of small molecule hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification. Curr. Med. Chem. 10:2003;733-739.
65. Simon J.A., Szankasi P., Nguyen D.K., Ludlow C., Dunstan H.M., Roberts C.J., Jensen E.L., Hartwell L.H., Friend S.H. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. Cancer Res. 60:2000;328-333.
66. Torrance C.J., Agrawal V., Vogelstein B., Kinzler K.W. Use of isogenic human cancer cells for high-throughput screening and drug discovery. Nat. Biotechnol. 19:2001;940-945.
67. Simons A., Dafni N., Dotan I., Oron Y., Canaani D. Establishment of a chemical synthetic lethality screen in cultured human cells. Genome Res. 11:2001;266-273.
68. Dolma S., Lessnick S.L., Hahn W.C., Stockwell B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 3:2003;285-296 Synthetic lethal screens are used to identify genotype-selective anti-tumour compounds with specific activity against cells bearing various combinations of six oncogenic genetic elements.
69. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., Burrows F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 425:2003;407-410 Increased affinity of the inhibitor 17-AAG for Hsp90 in tumour cells explains its selectivity as an anti-cancer agent.
70. Koeller K.M., Haggarty S.J., Perkins B.D., Leykin I., Wong J.C., Kao M.C., Schreiber S.L. Chemical genetic modifier screens. Small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. Chem. Biol. 10:2003;397-410 A demonstration of chemical suppression of a drug phenotype as a means to elaborate biological networks.
71. •].
72. Haggarty S.J., Koeller K.M., Wong J.C., Butcher R.A., Schreiber S.L. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol. 10:2003;383-396 Compounds from a high-throughput screen for tubulin- and lysine-deacetylase inhibitors are represented in a multidimensional space. Chemical structure correlates with both bioactivity and selectivity across different assays, allowing mapping of the deacetylase region of chemical space. Small-molecule inhibitors of tubulin deacetylation (tubacin) and histone deacetylation (histacin) are identified.
73. Haggarty S.J., Clemons P.A., Schreiber S.L. Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations. J. Am. Chem. Soc. 125:2003;10543-10545 Construction and visualization of a network of chemical genetic interactions with the spindle assembly and cell polarity networks. Activities of pairwise combinations of 24 bioactive small molecules (5760 perturbations) were represented as a 24- compound×24 - compound×10 -genotype matrix and visualized using clustering and dimensionality-reduction algorithms. None of the chemical genetic networks are identical, showing that small-molecule interactions reflect the architecture of the underlying genetic network.
74. Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R. et al. Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci USA. 100:2003;7977-7982 Approximately 120 000 pairwise combinations of small molecules are tested in dose matrices to uncover synergistic effects. Multicomponent therapeutics are isolated that inhibit the growth of fluconazole-resistant C. albicans, suppress the production of a cytokine in primary human blood cells, or inhibit the proliferation of cancer cells.
75. Cheok M.H., Yang W., Pui C.H., Downing J.R., Cheng C., Naeve C.W., Relling M.V., Evans W.E. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat. Genet. 34:2003;85-90 Gene expression patterns of cancer cells are assessed before and after treatment of acute lymphoblastic leukemia patients with methotrexate, mercaptopurine or both. Of the 124 genes that discriminate between treatments, only 14% of the genes whose expression levels change during either single-agent therapy also do so during combination therapy.
76. Cascante M., Boros L.G., Comin-Anduix B., de Atauri P., Centelles J.J., Lee P.W. Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 20:2002;243-249.
77. Graves P.R., Kwiek J.J., Fadden P., Ray R., Hardeman K., Coley A.M., Foley M., Haystead T.A. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol. Pharmacol. 62:2002;1364-1372 Displacement affinity chromatography is used to identify two new cellular targets of anti-malarial quinolines.
78. Tong AHY, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost R, Chang M et al.: Global mapping of the yeast genetic interaction network. Science 2003, in press.